Koomen, J. V., Heerspink, H. J. L., Schrieks, I. C., Schwartz, G. G., Lincoff, A. M., Nicholls, S. J., . . . Stevens, J. (2019). Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial. Diabetes Obes Metab.
Stile di citazione ChicagoKoomen, Jeroen V., et al. "Exposure and Response Analysis of Aleglitazar On Cardiovascular Risk Markers and Safety Outcomes: An Analysis of the AleCardio Trial." Diabetes Obes Metab 2019.
Citazione MLAKoomen, Jeroen V., et al. "Exposure and Response Analysis of Aleglitazar On Cardiovascular Risk Markers and Safety Outcomes: An Analysis of the AleCardio Trial." Diabetes Obes Metab 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.